Search

Your search keyword '"Klein, Reinhild"' showing total 204 results

Search Constraints

Start Over You searched for: Author "Klein, Reinhild" Remove constraint Author: "Klein, Reinhild" Search Limiters Full Text Remove constraint Search Limiters: Full Text
204 results on '"Klein, Reinhild"'

Search Results

1. TOFIMS mass spectrometry-based immunopeptidomics refines tumor antigen identification

4. The oncogenic fusion protein DNAJB1-PRKACA can be specifically targeted by peptide-based immunotherapy in fibrolamellar hepatocellular carcinoma

5. A COVID-19 peptide vaccine for the induction of SARS-CoV-2 T cell immunity

6. The HLA ligandome landscape of chronic myeloid leukemia delineates novel T-cell epitopes for immunotherapy

9. A new synthetic toll-like receptor 1/2 ligand is an efficient adjuvant for peptide vaccination in a human volunteer

11. Immunologic Findings in Workers Formerly Exposed to 2,3,7,8-Tetrachlorodibenzo-p-Dioxin and Its Congeners

12. Functional autoantibodies in systemic sclerosis: influence of autologous stem cell transplantation and correlation with clinical outcome.

14. Dynamics of Melanoma-Associated Epitope-Specific CD8+ T Cells in the Blood Correlate With Clinical Outcome Under PD-1 Blockade

15. Abstract 2008: The oncogenic fusion protein DNAJB1-PRKACA can be actively targeted by peptide-based immunotherapy in fibrolamellar hepatocellular carcinoma

18. Functionally Active Antibodies to the Angiotensin II Type 1-Receptor Measured by a Luminometric Bioassay Do Not Correlate With Clinical Manifestations in Systemic Sclerosis: A Comparison With Antibodies to Vascular Receptors and Topoisomerase I Detected by ELISA

19. Evaluation of Inhibitory Antibodies against the Muscarinic Acetylcholine Receptor Type 3 in Patients with Primary Biliary Cholangitis and Primary Sclerosing Cholangitis

20. A COVID-19 peptide vaccine for the induction of SARS-CoV-2 T cell immunity

22. Designing a SARS-CoV-2 T-Cell-Inducing Vaccine for High-Risk Patient Groups

23. Increased Concentrations of Circulating Soluble MHC Class I-Related Chain A (sMICA) and sMICB and Modulation of Plasma Membrane MICA Expression: Potential Mechanisms and Correlation With Natural Killer Cell Activity in Systemic Lupus Erythematosus

25. Einfluss einer autologen Stammzelltransplantation auf funktionelle Autoantikörper gegen den Angiotensin Typ 1 Rezeptor bei Patienten mit progressiver systemischer Sklerodermie

26. Defibrotide for the treatment of PIMS-TS in two pediatric patients

28. HLA Evolutionary Divergence as a Prognostic Marker for AML Patients Undergoing Allogeneic Stem Cell Transplantation

29. Antibodies to the Muscarinic Acetylcholine Receptor M3 in Primary Biliary Cholangitis Inhibit Receptor Function on Cholangiocytes

30. Safety and Vision Outcomes of Subretinal Gene Therapy Targeting Cone Photoreceptors in Achromatopsia

31. Additional file 1 of Inhibition of effector B cells by ibrutinib in systemic sclerosis

32. Defibrotide for the Treatment of Pediatric Inflammatory Multisystem Syndrome Temporally Associated With Severe Acute Respiratory Syndrome Coronavirus 2 Infection in 2 Pediatric Patients

34. Large expert-curated database for benchmarking document similarity detection in biomedical literature search

36. Analysis of the clinical relevance of antimitochondrial antibodies to the β- and γ-subunits of the F1F0-ATPase in patients with primary biliary cirrhosis

38. Additional file 2: of Sulphite oxidase (SO) â a mitochondrial autoantigen as target for humoral and cellular immune reactions in primary sclerosing cholangitis

39. Additional file 4: of Sulphite oxidase (SO) â a mitochondrial autoantigen as target for humoral and cellular immune reactions in primary sclerosing cholangitis

40. Additional file 1: of Sulphite oxidase (SO) – a mitochondrial autoantigen as target for humoral and cellular immune reactions in primary sclerosing cholangitis

41. Additional file 5: of Sulphite oxidase (SO) – a mitochondrial autoantigen as target for humoral and cellular immune reactions in primary sclerosing cholangitis

42. Mistletoe therapy in primary and recurrent inoperable pancreatic cancer. A phase III prospective, randomized, double-blinded, multicenter, parallel group, placebo-controlled clinical trial on overall survival and health-related quality of life (MISTRAL)

43. The HLA Ligandome Landscape of Chronic Myeloid Leukemia Delineates Novel T-Cell Epitopes for Immunotherapy

44. The Common Food Additive Carrageenan Increases Intestinal Permeability without Affecting Whole-Body Insulin Sensitivity in Humans—Results from a Randomized, Double-Blind Crossover Study

45. HLA ligandome analysis of primary chronic lymphocytic leukemia (CLL) cells under lenalidomide treatment confirms the suitability of lenalidomide for combination with T-cell-based immunotherapy

46. AAV8 Can Induce Innate and Adaptive Immune Response in the Primate Eye

48. High incidence of antibodies to lens proteins in sera from patients with uveitis

49. Immunodiagnostics and immunosensor design

50. Mistletoe lectin- (ML-1) and viscotoxin (VT) antibodies during therapy with Viscum album in patients with breast cancer

Catalog

Books, media, physical & digital resources